Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Status:
Not yet recruiting
Trial end date:
2027-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if experimental drug treatment improves recovery
after TBI as compared to a control (placebo) group. Changes in recovery will be measured
throughout the study. The study drugs listed below are approved by the U.S. Food and Drug
Administration (FDA) but are being used "off-label" in this study. This means that the drugs
are not currently approved to treat TBI.